-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BauZhGKIrZOQrdNeoFkie7oZSO/R5YGjkkMt8aepgsZnExUbFOLawFAJSJiAkOkx Nd+Zs+iTNzlazxzr80a3VA== 0000904511-01-500007.txt : 20010710 0000904511-01-500007.hdr.sgml : 20010710 ACCESSION NUMBER: 0000904511-01-500007 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20010706 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 20010706 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOMEDIX INC CENTRAL INDEX KEY: 0001091596 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 232958959 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-28443 FILM NUMBER: 1675923 BUSINESS ADDRESS: STREET 1: 1523 BOWMAN RD SUITE A CITY: LITTLE ROCK STATE: AR ZIP: 72211 BUSINESS PHONE: 5012258400 MAIL ADDRESS: STREET 1: 1523 BOWMAN RD SUITE A CITY: LITTLE ROCK STATE: AR ZIP: 72211 FORMER COMPANY: FORMER CONFORMED NAME: AUTOLOGOUS WOUND THERAPY INC DATE OF NAME CHANGE: 20000407 8-K 1 cyto8k.txt 8-K FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 6, 2001 Cytomedix, Inc. ------------------------ (Exact name of registrant as specified in charter) Delaware 0-28443 23-3011702 -------- ------- ---------- (State of (Commission (IRS Employer Organization) File Number) Identification No.) Three Parkway North Deerfield, Illinois 60015 ------------------- ----- (Address of principal executive offices) (Zip Code) Registrant's Telephone Number, including area code: (847) 405-7800 ------------- Former name or former address, if changed since last report: Not Applicable Item 5. Other Events ------------ On June 29, 2001, we made significant and material reductions in our sales, marketing, management, and support personnel to conserve available cash. We closed down all of our Procuren processing centers, accelerating our earlier plan to terminate such operations during July. We are operating with minimal staff. We continue to evaluate our financing options and will continue to explore our strategic alternatives. Item 7. Financial Statements and Exhibits --------------------------------- (a) Financial Statements of Business Acquired. Not applicable. (b) Unaudited Pro Forma Combined Financial Information. Not applicable. (c) Exhibits. Not applicable SIGNATURES ---------- Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Cytomedix, Inc. By: /s/ James A. Cour --------------------------------------- James A. Cour Chief Executive Officer and President Date: July 6, 2001 -----END PRIVACY-ENHANCED MESSAGE-----